Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy

Met is a receptor tyrosine kinase that promotes cancer progression. In addition, Met has been implicated in resistance of tumors to various targeted therapies such as EGFR inhibitors in lung cancers, and has been prioritized as a key molecular target for cancer therapy. However, the underlying mecha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncogene
Main Authors: Kim, Bogyou, Wang, Shangzi, Lee, Ji Min, Jeong, Yunju, Ahn, TaeJin, Son, Dae-Soon, Park, Hye Won, Yoo, Hyeon-seok, Song, Yun-Jeong, Lee, Eunjin, Oh, Young Mi, Lee, Saet Byoul, Choi, Jaehyun, Murray, Joseph C, Zhou, Yan, Song, Paul H, Kim, Kyung-Ah, Weiner, Louis M
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300291/
https://ncbi.nlm.nih.gov/pubmed/24662823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2014.51
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados